Related Experiment Videos

Regulation of p73 by c-Abl through the p38 MAP kinase pathway

Ricardo Sanchez-Prieto1, Victor Javier Sanchez-Arevalo, Joan-Marc Servitja

  • 1Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892-4330, USA.

Oncogene
|February 13, 2002
PubMed

Insights

The p38 MAP kinase pathway regulates the tumor suppressor p73, a protein related to p53. This pathway enhances p73 stability and is crucial for c-Abl

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • p73 is a tumor suppressor protein in the p53 family, crucial for cellular differentiation and DNA damage response.
  • Mechanisms controlling p73 activity remain largely unknown.
  • c-Abl, a tyrosine kinase activated by DNA damage, targets p73.

Purpose of the Study:

  • To elucidate the molecular mechanisms regulating p73 activity, specifically the role of c-Abl and associated signaling pathways.
  • To investigate the involvement of the p38 MAP kinase pathway in c-Abl-mediated regulation of p73.

Main Methods:

  • Investigated c-Abl-induced phosphorylation of p73.
  • Utilized p38 MAP kinase pathway activators and inhibitors.
  • Assessed p73 stability and transcriptional activity.

Main Results:

  • c-Abl induces phosphorylation of p73 at specific threonine residues.
  • The p38 MAP kinase pathway mediates c-Abl's effects on p73.
  • p38 activation enhances p73 protein stability.
  • Transcriptional activation of p73 by c-Abl is dependent on p38 activity.

Conclusions:

  • The p38 MAP kinase pathway is a key regulator of p73 activity.
  • c-Abl utilizes the p38 pathway to modulate p73 stability and function.
  • This study reveals a novel signaling pathway involving MAP kinases in the regulation of p73.

Related Concept Videos